Annual report pursuant to section 13 and 15(d)

2. Summary of Significant Accounting Policies (Details Narrative)

v2.4.0.8
2. Summary of Significant Accounting Policies (Details Narrative) (USD $)
 3 Months Ended 10 Months Ended 12 Months Ended 190 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 1998
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2008
Dec. 31, 2007
Dec. 31, 2006
Dec. 31, 2005
Dec. 31, 2004
Dec. 31, 2003
Dec. 31, 2002
Dec. 31, 2001
Dec. 31, 2000
Dec. 31, 1999
Dec. 31, 2013
Feb. 17, 1998
Net loss $ (8,873,734) $ (1,445,125) $ (1,920,950) $ 1,582,800 $ (1,553,735) $ (4,670,704) $ (1,397,598) $ (5,470,350) $ (21,307) $ (10,657,009) $ (13,092,387) $ (10,856,547) $ (9,494,906) $ (6,194,950) $ (6,052,724) $ (6,262,743) $ (10,181,523) $ (3,115,186) $ (6,803,280) $ (2,476,063) $ (2,749,199) $ (2,735,013) $ (1,270,762) $ (1,075,264) $ (93,038,863)  
Negative cash flow from operations                   (5,912,368) (4,517,585) (4,723,952)                         (38,632,070)  
Cash on Hand 4,137,068       1,601,791         4,137,068 1,601,791 617,797 101,645                       4,137,068 0
Impairment on long-lived assets                   0 0                              
Loss per Share                                                    
Research and development expenses                   $ 2,011,486 $ 963,184 $ 1,318,783                         $ 10,681,167  
Options
                                                    
Loss per Share                                                    
Antidilutive shares excluded from loss per share                   20,309,908 27,278,098 24,067,892                            
Warrants
                                                    
Loss per Share                                                    
Antidilutive shares excluded from loss per share                   11,763,966 42,205,507 49,106,280                            
Convertible Notes
                                                    
Loss per Share                                                    
Antidilutive shares excluded from loss per share                   0 0 6,836,016